Changli Wang - Concepedia

Author

Changli Wang

Tianjin Medical University Cancer Institute and Hospital ORCID

Also Known As

Chang-Li Wang, Changli Wang, Peixiang Ni

Publications

748

Citations

H-Index

Concepts

All Affiliations

Tianjin Medical University Cancer Institute and Hospital

About

Changli Wang is an author at Tianjin Medical University Cancer Institute and Hospital specializing in medicine, lung cancer, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	295
2	Cell Biology	2	2	219
3	Health Sciences	1	1	76
4	Pathology	1	1	36
5	Surgical Oncology	1	1	76

Changli Wang

Publications

584

Citations

H-Index

Page 1

	Year	Citations
MiR-26a enhances metastasis potential of lung cancer cells via AKT pathway by targeting PTEN Boning Liu, Xiang Wu, Bin Liu, Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease Mir-26a EnhancesOncologyAkt PathwayMedicineMicrorna Detection	2012	183
Perioperative tislelizumab plus neoadjuvant chemotherapy for patients with resectable non-small-cell lung cancer (RATIONALE-315): an interim analysis of a randomised clinical trial Dongsheng Yue, Wenxiang Wang, Hongxu Liu, The Lancet Respiratory Medicine Interim AnalysisSurgical OncologyNeoadjuvant ChemotherapyMedicineMetronomic Therapy	2024	76
MicroRNA‐130b targets PTEN to induce resistance to cisplatin in lung cancer cells by activating Wnt/β‐catenin pathway Qiang Zhang, Bin Zhang, Leina Sun, Cell Biochemistry and Function	2018	62
Plasma miR-324-3p and miR-1285 as diagnostic and prognostic biomarkers for early stage lung squamous cell carcinoma Xujie Gao, Yang Wang, Hua Zhao, Oncotarget	2016	55
Injectable hydrogel with doxorubicin-loaded ZIF-8 nanoparticles for tumor postoperative treatments and wound repair Qiang Zhang, Yu Zhang, Hui Chen, Scientific Reports	2024	37
miR‑195 suppresses metastasis and angiogenesis of squamous cell lung cancer by inhibiting the expression of VEGF Hailin Liu, Yulong Chen, Yue Li, Molecular Medicine Reports Sqclc Cell LinesSqclc CellsOncologyMirnas ActMedicine	2019	36
<p>MiR-29b-3p Reverses Cisplatin Resistance by Targeting COL1A1 in Non-Small-Cell Lung Cancer A549/DDP Cells</p> Rui Jia, Changli Wang Cancer Management and Research	2020	32
BCL9 promotes epithelial mesenchymal transition and invasion in cisplatin resistant NSCLC cells via β-catenin pathway Yu Zhang, Qiang Zhang, Hui Chen, Life Sciences	2018	26
Integrated Multiomics Analyses Revealing Different Molecular Profiles Between Early- and Late-Stage Lung Adenocarcinoma Dongsheng Yue, Weiran Liu, Liuwei Gao, Frontiers in Oncology	2021	18
Theta/beta ratio in EEG correlated with attentional capacity assessed by Conners Continuous Performance Test in children with ADHD Tzong‐Shi Wang, Syu‐Siang Wang, Changli Wang, Frontiers in Psychiatry	2024	18

Page 1